Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.

A J Witkamp1, E de Bree, R Van Goethem

  • 1Department of Surgical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, CX 1066 Amsterdam, the Netherlands.

Cancer Treatment Reviews
|March 23, 2002
PubMed
Summary

Surgical cytoreduction with hyperthermic intraperitoneal chemotherapy (HIPEC) offers a promising treatment for peritoneal surface malignancy. This approach leverages enhanced drug delivery and hyperthermia for improved outcomes in select patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.

Virchows Archiv : an international journal of pathology·2025
Same author

Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study.

Breast (Edinburgh, Scotland)·2023
Same author

Patient-Reported Symptoms of Late Toxicity in Patients With Breast Cancer Treated With Hypofractionated Radiation Therapy and the Association With Quality of Life.

International journal of radiation oncology, biology, physics·2022
Same author

Feasibility of Narrow-Band Imaging, Intraductal Biopsy, and Laser Ablation During Mammary Ductoscopy: Protocol for an Interventional Study.

International journal of surgery protocols·2022
Same author

Effects of structured involvement of the primary care team versus standard care after a cancer diagnosis on patient satisfaction and healthcare use: the GRIP randomised controlled trial.

BMC primary care·2022

Area of Science:

  • Oncology
  • Surgical Oncology
  • Chemotherapy

Background:

  • Peritoneal surface malignancy presents complex treatment challenges.
  • Surgical cytoreduction combined with intra-operative hyperthermic intraperitoneal chemotherapy (HIPEC) is an emerging therapeutic strategy.

Purpose of the Study:

  • To review the rationale, prerequisites, and techniques of cytoreductive surgery followed by HIPEC.
  • To evaluate the clinical value and evidence supporting this combined treatment modality.

Main Methods:

  • A comprehensive literature search was conducted using PubMed.
  • The review synthesizes findings on pharmacokinetics, hyperthermia effects, and clinical data.

Main Results:

  • Intraperitoneal chemotherapy offers a pharmacokinetic advantage over intravenous administration.

Related Experiment Videos

  • Hyperthermia enhances drug penetration into tumor tissue and exhibits synergistic effects.
  • HIPEC is most effective in patients with minimal residual disease post-cytoreduction.
  • Randomized studies confirm HIPEC's value in gastric cancer prevention of peritoneal dissemination.
  • Phase II data for colorectal carcinomatosis and pseudomyxoma peritonei are promising.

    • Conclusions:

    • Aggressive cytoreductive surgery combined with HIPEC is a rational approach for peritoneal surface malignancy.
    • This combined treatment demonstrates significant clinical value, particularly in specific oncological indications.